- Home
- VGZ vs CSBR Comparison
VGZ vs CSBR Comparison
Compare VGZ & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VGZ
- CSBR
- Stock Information
- Founded
- VGZ 1983
- CSBR 1985
- Country
- VGZ United States
- CSBR United States
- Employees
- VGZ N/A
- CSBR N/A
- Industry
- VGZ
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VGZ
- CSBR Health Care
- Exchange
- VGZ Nasdaq
- CSBR Nasdaq
- Market Cap
- VGZ 71.2M
- CSBR 60.6M
- IPO Year
- VGZ N/A
- CSBR 1986
- Fundamental
- Price
- VGZ $0.70
- CSBR $5.23
- Analyst Decision
- VGZ Strong Buy
- CSBR Strong Buy
- Analyst Count
- VGZ 1
- CSBR 2
- Target Price
- VGZ $2.75
- CSBR $6.75
- AVG Volume (30 Days)
- VGZ 401.2K
- CSBR 129.1K
- Earning Date
- VGZ 10-23-2024
- CSBR 09-11-2024
- Dividend Yield
- VGZ N/A
- CSBR N/A
- EPS Growth
- VGZ N/A
- CSBR N/A
- EPS
- VGZ 0.09
- CSBR N/A
- Revenue
- VGZ N/A
- CSBR $51,655,000.00
- Revenue This Year
- VGZ N/A
- CSBR $9.14
- Revenue Next Year
- VGZ N/A
- CSBR $10.03
- P/E Ratio
- VGZ $7.49
- CSBR N/A
- Revenue Growth
- VGZ N/A
- CSBR N/A
- 52 Week Low
- VGZ $0.30
- CSBR $3.60
- 52 Week High
- VGZ $0.73
- CSBR $7.13
- Technical
- Relative Strength Index (RSI)
- VGZ 71.91
- CSBR 67.10
- Support Level
- VGZ $0.53
- CSBR $3.60
- Resistance Level
- VGZ $0.63
- CSBR $5.23
- Average True Range (ATR)
- VGZ 0.04
- CSBR 0.35
- MACD
- VGZ 0.01
- CSBR 0.10
- Stochastic Oscillator
- VGZ 99.90
- CSBR 87.57
About VGZ Vista Gold Corp
Vista Gold Corp is a gold mining company. It is engaged in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects. The company evaluate, acquire, explore and advance gold exploration and potential development projects, which may lead to gold production or value adding strategic transactions. These activities are currently focused principally in Australia.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. They derive revenue primarily from research services.